Medical Malpractice

Lopez McHugh partner gets national honor

Ramon Rossi Lopez, a partner with Lopez McHugh, has been included in the 19th edition of The Best Lawyers in America, for his work in the practice area of Mass Tort Litigation/Class Actions — Plaintiffs.

Selection for Best Lawyers is based on an exhaustive and rigorous peer-review survey involving more than 4 million confidential evaluations by the top attorneys in the country. No fee or purchase is required, which makes ...

continue reading...

Lopez McHugh lawyer rated “AV Preeminent”

Inside Jersey magazine has designated James McHugh of Lopez McHugh one of “New Jersey’s Top Rated Lawyers” in the magazine’s August issue.

James is listed among the state’s most highly rated medical malpractice attorneys.

According to Inside Jersey, the list is created by LexisNexis Martindale-Hubbell. It’s based on a database of confidential peer review ratings from lawyers and members of the judiciary, who are asked via an online survey or by ...

continue reading...

Patients rights groups oppose federal legislation that limits compensation for injury

Many patients’ rights groups are criticizing a measure that passed in the U.S. House of Representatives last week, which would restrict patients’ ability to pursue claims against negligent medical providers, including drug and medical device manufacturers.

According to Public Citizen, H.R. 5, the Protecting Access to Healthcare (PATH) Act, imposes an arbitrary $250,000 cap on non-economic damages, which would have a disproportionate impact on those with little or no earned income, such as children, full-time mothers and seniors.

Conservative groups such as ...

continue reading...

Dennis Quaid Sheds Light On Avoidable Medical Errors and FDA Attempts to Shield Pharmaceutical Companies From Liability

May 14, 2008 – Actor Dennis Quaid testified before the Congressional Committee on Oversight and Government Reform in a hearing entitled, “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?” The issue was whether FDA approval of a drug or medical device should prevent private persons from suing the manufacturers of those drugs or devices, a doctrine called “preemption.” Other notable testimony against preemption came from New England Journal of Medicine editor Gregory Curfman and former ...

continue reading...
Page 7 of 7 «...34567